Sanctuary Advisors LLC Buys Shares of 11,007 Agilent Technologies, Inc. $A

Sanctuary Advisors LLC purchased a new position in Agilent Technologies, Inc. (NYSE:A) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm purchased 11,007 shares of the medical research company’s stock, valued at approximately $1,462,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Core Wealth Advisors LLC bought a new position in Agilent Technologies during the 4th quarter worth approximately $26,000. SHP Wealth Management acquired a new stake in Agilent Technologies in the fourth quarter worth $26,000. Navalign LLC acquired a new position in shares of Agilent Technologies in the 4th quarter valued at $27,000. Cedar Mountain Advisors LLC bought a new stake in shares of Agilent Technologies in the 1st quarter valued at $27,000. Finally, MV Capital Management Inc. acquired a new stake in Agilent Technologies during the 4th quarter worth $28,000.

Wall Street Analysts Forecast Growth

A has been the topic of several recent analyst reports. TD Cowen lifted their target price on Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Weiss Ratings raised Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, June 2nd. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Sunday, August 2nd. Piper Sandler initiated coverage on Agilent Technologies in a research note on Thursday, June 11th. They set a “neutral” rating and a $150.00 target price for the company. Finally, HSBC dropped their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. Two research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $160.24.

Trending Headlines about Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 revenue of $1.88 billion, up 8.1% year over year and ahead of the roughly $1.84 billion consensus estimate. Adjusted EPS of $1.62 exceeded estimates near $1.48-$1.49 and rose from $1.37 a year earlier. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Profitability and cash generation strengthened. Operating profit increased 23.3% to $444 million, operating cash flow rose 43.4% to $519 million, and the company ended the quarter with $1.8 billion in cash. GAAP net income reached $362 million, or $1.28 per diluted share, versus $336 million, or $1.18, a year earlier. Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: Agilent raised fiscal 2026 adjusted EPS guidance to $6.18-$6.21, above the approximately $6.06 consensus, and projected revenue of about $7.5 billion versus expectations near $7.4 billion. Management cited improving laboratory-tools demand. Fourth-quarter guidance was broadly in line with analyst estimates. Agilent Raises Annual Profit Forecast
• Neutral Sentiment: Institutional investor positioning was mixed: 594 investors increased holdings in the latest quarter, while 550 reduced positions. Recent analyst targets have a median of $155, suggesting limited near-term upside relative to the recent trading level.
• Negative Sentiment: Despite the earnings beat, Agilent trades at a relatively demanding valuation, with a P/E ratio above 31, and the stock is close to its 12-month high. This could make the shares more sensitive to any slowdown in laboratory-equipment demand or future guidance disappointments.

Agilent Technologies Stock Performance

A opened at $155.16 on Thursday. The business’s 50-day moving average price is $139.16 and its two-hundred day moving average price is $126.65. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.51. The company has a market capitalization of $43.82 billion, a price-to-earnings ratio of 31.16, a P/E/G ratio of 2.73 and a beta of 1.25. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, beating analysts’ consensus estimates of $1.49 by $0.13. The company had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company’s quarterly revenue was up 8.1% compared to the same quarter last year. During the same period in the previous year, the company posted $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Equities analysts expect that Agilent Technologies, Inc. will post 6.05 EPS for the current fiscal year.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.